Aarti Drugs reports strong Q3 profit and announces buyback
pre-market1 source ↓written by the desknot a recommendation
Aarti Drugs reported robust profit growth for Q3 FY26, with revenue rising significantly. The company declared an interim dividend and successfully completed a share buyback. Additionally, operations commenced at a new plant in Gujarat, bolstering future growth prospects. 📈
These developments may enhance investor sentiment and support stock performance in the near term.
Not investment advice. For informational purposes only.